糜蛋白酶

基本解释 (translations)

chymotrypsin

与糜蛋白酶相关的网络例句 [注：此内容来源于网络，仅供参考]

objective to investigate the clinical therapeutic effect of mucosolvan nebulization in infants with pneumonia.methods 96 infants were randomly divided into and control group.regular treatment were given to control group,meanwhile,based on regular treatment,the infants in observation group were also received mushutan nebulization.the disappearing time of cough、wheezy phlegm、anhelation、wheezy sound in lung and admission duration were evatated.results the disappearing time of wheezy phlegm、wheezy sound in lung and admission duration in observation group were shorten than in control group(p.05).conclusion mucosolvan nebulization can raise clinical therapeutic effect for pneumonia in infants with pneumonia.especially in eliminating phlegm and disappearing of wheezy sound in lung.

摘要］ 目的：为探讨沐舒坦雾化吸入辅助治疗婴幼儿肺炎的效果。方法：将96例婴幼儿肺炎随机分成两组，两组均在常规抗感染，纠正缺氧、酸碱平衡、电解质紊乱，治疗组加用沐舒坦雾化吸入，对照组用α糜蛋白酶、地塞米松雾化吸入。对两组的咳嗽、痰鸣、气促、肺部湿音的消失时间及住院时间进行比较。结果：使用沐舒坦雾化吸入的治疗组在治疗痰鸣、肺部湿音消失时间及住院时间比对照组短（p.05）。结论：沐舒坦雾化吸入可提高婴幼儿肺炎治疗效果，尤其祛痰和减少肺部湿性音的效果较好。

Objective To investigate the effect of chymotrypsin in decreasing the rate of postoperative adhesion.

目的 探讨糜蛋白酶对肌腱粘连的影响。

This Product is high in Trypsin/Chymotrypsin.

该产品是高胰蛋白酶/糜蛋白酶。

Antibiotics may be necessary to join and chymotrypsin to control infection and promote Reiner.

必要时可加入抗生素和糜蛋白酶，以控制感染和促进排痰。

urokinase and chymotrypsin are effective and safe method for treating of multiloculated pleural effusions.

尿激酶和糜蛋白酶治疗有小房形成的胸腔积液安全而有效。

Subsequent experiments with over-expression and RNAi further established that chymotrypsin upregulation was a ...

其后，通过将糜蛋白酶基因过表达和RNA干涉，进一步证实糜蛋白酶基因上调是引起溴氰菊酯抗性的原因之一。

The results showed that the optimal pH were 2.0 and 6.5~7.5 for gastric protease and amylase,10.5 and 6.5 for intestinal protease and amylase and 7.5 and 8.0 for intestinal trypsin and chymotrypsin,respectively.

结果表明：胃蛋白酶和淀粉酶的最适pH分别为2.0和6.5~7.5，肠蛋白酶和淀粉酶的最适pH分别为10.5和6.5，肠胰蛋白酶、糜蛋白酶的最适pH分别为8.5和8.0。

In this paper we combined three chromatographic separation and purification technique such as affinity chromatography, ion exchanger chromatography and hydrophobic interaction chromatography to develope a new technology of stimutaneous extraction of three enzyme from pancreatin. We optimized the technology by studying the methods of purification and assured the technology as: The crude extraction from the dissolution of Pancreatin is directly absorbed on the DEAE gelose fast flow columnEquilibrating buffer is 0.01mol/L NaoAc-HoAc buffer(pH4.5; eluting buffer is 0.2～0.35mol/LNaCl in 0.01mol/LNaoAc-HoAc buffer (pH4.5), and then be eluted by two steps to acquire the peak of kallikrein.The solution which can"t be adsorbed by DEAE gelose fast flow column is adsorbed on affinity chromatographic column Equilibrating buffer is 0.01mol/LTris-HCl buffer(pH7.5, eluting buffer is 0.5mol/LNaCl in 0.01mol/Ltris-HCl buffer(pH7.5)and then be eluted by one step to acquire the peak of trypsin.The solution which can"t be adsorbed by is pretreated with 30%～80%(NH_4)_2SO_4 fractional precipitation, the deposition of the precipitation is dissolved to beabsorbed on phenyl gelose fast flow columnhydrophobic interaction chromatography condition is Equilibrating buffer is lmol/L(NH_4_2SO_4 in 0.01mol/LNaoAc-HoAc buffer(pH4.5), eluting buffer is 0～0.6mol/L(NH_4)_2SO_4 in 0.01mol/LNaoAc-HoAc buffer (pH4.5) and then be eluted by two steps to acquire the peak of chymotrypsin.

本研究考察了各种纯化方法，将离子交换层析、亲和层析和疏水层析三种分离纯化法相结合，建立了激肽释放酶、胰蛋白酶和糜蛋白酶三酶的联产工艺：胰酶用pH4.5醋酸缓冲溶液提取后，粗提液直接上DEAE-琼脂糖快胶柱吸附平衡缓冲液：0.01mol／LNaoAc-HoAc缓冲液(pH4.5，洗脱缓冲液：0.01mol／LNaoAc-HoAc缓冲液(pH4.5)含0.2～0.35mol／LNaCl分两步洗脱，收集激肽释放酶的洗脱峰；DEAE-琼脂糖快胶的未吸附液上亲和层析柱分批吸附平衡缓冲液：0.01mol／LTris-HCl缓冲液(pH7.5，洗脱液：0.5mol／LNaCl溶液，一次洗脱，收集胰蛋白酶洗脱峰；最后，亲和层析未吸附液用30％～80％硫酸铵分级盐析处理，沉淀溶解后用上苯基—琼脂糖快胶吸附平衡缓冲液：0.01mol／LNaAc-HAc缓冲液(pH4.5含1mol／L(NH_4)_2SO_4，洗脱缓冲液：0.01mol／LNaAc-HAc缓冲液(pH4.5)含0～0.6mol／L(NH_4)_2SO_4，分两步洗脱，收集糜蛋白酶的洗脱峰。

But there are few or no visible F-actin ring of blocking proteinase being released in MC of tryptase and chymase immunoreactivity MC(subscript TC and MC of chymase immunoreactivity MC(subscript C. Cell appearance was inflated and intracellular proteinase had been released.

而类胰蛋白酶和类糜蛋白酶免疫反应性的肥大细胞及类糜蛋白酶免疫反应性的肥大细胞内少见或未见明显的阻碍蛋白酶释放的丝状肌动蛋白环；细胞形态膨胀，细胞内蛋白酶已释放。

Results:Three immunophenotypes were determined: MCs positive for tryptase, no immunodetectable chymase; MCs positive for chymase, no immunodetectable tryptase ; and MCs positive for tryptase and chymase .

结果：三种免疫表型被确定：肥大细胞的类胰蛋白酶阳性、类糜蛋白酶阴性；类糜蛋白酶阳性、类胰蛋白酶阴性和类胰蛋白酶阳性、类糜蛋白酶阳性。

与糜蛋白酶相关的网络解释 [注：此内容来源于网络，仅供参考]

chymotrypsin：糜蛋白酶

动力宝含有一些植物成分,比如菠萝酶(bromelain,从菠萝中提取的)和木瓜酶(papain,从木瓜中提取的),糜蛋白酶(chymotrypsin)和胰蛋白酶(trypsin)以及类黄酮芦丁(rutin).

chymotrypsin：胰凝乳蛋白酶,糜蛋白酶

chymostatin 胰凝乳蛋白酶抑制剂[分为A、B、C三种] | chymotrypsin 胰凝乳蛋白酶,糜蛋白酶 | chymotrypsinogen 胰凝乳蛋白酶原

Chymotrypsin PDF：糜蛋白酶

BBI7 胆固醇氧化酶 Cholesterol oxidase PDF | BBI8 糜蛋白酶 Chymotrypsin PDF | BBI9 糜蛋白酶原 Chymotrypsinogen PDF

chymotrypsinogen：糜蛋白酶原

chymosin 凝乳酶 | chymotrypsinogen 糜蛋白酶原 | chymotrypsinogen 胰凝乳蛋白酶原

chymotrypsinogen：胰凝乳蛋白酶原,糜蛋白酶原

chymotrypsin胰凝乳蛋白酶;糜蛋白酶 | chymotrypsinogen胰凝乳蛋白酶原;糜蛋白酶原 | chymotrptichydrolysis胰蛋白酶水解(作用)

Chymotrypsinogen PDF：糜蛋白酶原

BBI8 糜蛋白酶 Chymotrypsin PDF | BBI9 糜蛋白酶原 Chymotrypsinogen PDF | BBI10 肌酸(脱水)酶 Creatinase PDF

lipocaic：胰抗脂肝素

胰脏是兼有内分泌和外分泌功能的腺体,含有的酶类最丰富,是动物体中的"酶库". 含有胰岛素、胰高血糖素、胰酶、糜蛋白酶、胰脂酶、胶原酶、增压素水解酶、胆碱酯酶、弹性蛋白酶、血管舒缓素、胰抗脂肝素(Lipocaic)、胰降压素(Depropanex)等.

chymase：糜蛋白酶

目的 通过观察链脲菌素(STZ)诱导糖尿病仓鼠心肌病变中糜蛋白酶(chymase)的活性变化,探讨chymase在糖尿病仓鼠心肌病变形成中的作用及机制.方法 20只8周龄雌性仓鼠,随机分为对照组10只,糖尿病组10只,腹腔注射STZ 40 mg/d,连续3天,

chymotry inogen：胰凝乳蛋白酶原

chymotry in|胰凝乳蛋白酶,糜蛋白酶 | chymotry inogen|胰凝乳蛋白酶原 | chytrid|壶菌[一类真菌]

elastase：弹性蛋白酶

1.蛋白水解酶胰液中的蛋白水解酶主要有胰蛋白酶(trypsin)、糜蛋白酶(chymotrypsin)、弹性蛋白酶(elastase)和羧基肽酶(carboxypeptidase)等,它们均以酶原的形式贮存于腺泡细胞内和被分泌.